Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble. ALLISON GATLIN Investor’s Business Daily

Novo Nordisk stock dropped Monday after the drugmaker licensed a Chinese competitor’s weight-loss drug for $200 million up front.

The post Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble. appeared first on Investor’s Business Daily.

Novo Nordisk stock dropped Monday after the drugmaker licensed a Chinese competitor’s weight-loss drug for $200 million up front.

The post Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble. appeared first on Investor’s Business Daily.

 Novo Nordisk stock dropped Monday after the drugmaker licensed a Chinese competitor’s weight-loss drug for $200 million up front.
The post Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble. appeared first on Investor’s Business Daily.   Read MoreTechnology, All News And Stock Ideas, Biotech And Pharma Stock News, Weight-Loss Drugs Investor’s Business Daily